A very high incidence of low 25 hydroxy-vitamin D serum concentration in a French population of patients with primary hyperparathyroidism
Authors:
- 1 June 2006
- journal article
- Published by Springer Nature in Journal of Endocrinological Investigation
- Vol. 29 (6) , 511-515
Abstract
Since the demonstration that vitamin D status might influence the clinical and biological expression of primary hyperparathyroidism (PHPT), a serum 25-hydroxy vitamin D (25-OHD) concentration of 50 nmol/l has been considered by an expert panel as the minimum level to be maintained in asymptomatic PHPT patients. Two yr after this recommendation, we aimed to evaluate the frequency of serum 25-OHD concentrations below this threshold in PHPT patients. In the present study, serum 25-OHD, second- and third-generation PTH, calcium, phosphate, magnesium, albumin and creatinine were measured in 72 out 145 consecutive PHPT patients operated on in our Endocrine Surgery Department, in whom blood samples were available before as well as two days after surgical intervention. Before surgery, the frequency of serum 25-OHD levels 3 vs >3 mmol/l. 25-OHD concentrations correlated negatively with the weight of adenoma, PTH levels, and total calcium concentrations measured before surgery. Pre-operative PTH levels, whatever the assay used, and total calcium concentrations were positively and significantly correlated. Two days post-surgery, 13 patients were moderately hypocalcemic. Neither pre-surgery 25-OHD nor PTH, calcium or phosphorus level or adenoma weight were predictive of post-operative hypocalcemia. The dramatic frequency of low 25-OHD concentrations in our PHPT patients demonstrates that the above-mentioned recommendation is far from being applied in France despite evidence of worsening expression of PHPT with decreasing 25-OHD serum levels.Keywords
This publication has 20 references indexed in Scilit:
- Third- or Second-Generation Parathyroid Hormone Assays: A Remaining Debate in the Diagnosis of Primary HyperparathyroidismThe Journal of Clinical Endocrinology & Metabolism, 2005
- Vitamin D status, seasonal variations, parathyroid adenoma weight and bone mineral density in primary hyperparathyroidismClinical Endocrinology, 2005
- Vitamin D Repletion in Patients with Primary Hyperparathyroidism and Coexistent Vitamin D InsufficiencyThe Journal of Clinical Endocrinology & Metabolism, 2005
- Recovery of Bone Mineral Density in 126 Patients after Surgery for Primary HyperparathyroidismWorld Journal of Surgery, 2004
- Technical and Clinical Characterization of the Bio-PTH (1–84) Immunochemiluminometric Assay and Comparison with a Second-Generation Assay for Parathyroid HormoneClinical Chemistry, 2004
- Sex Steroids, Mice, and Men: When Androgens and Estrogens Get Very Close to Each OtherJournal of Bone and Mineral Research, 2002
- Development of a Novel Immunoradiometric Assay Exclusively for Biologically Active Whole Parathyroid Hormone 1–84: Implications for Improvement of Accurate Assessment of Parathyroid FunctionJournal of Bone and Mineral Research, 2001
- Effect of Vitamin D Nutrition on Parathyroid Adenoma Weight: Pathogenetic and Clinical Implications*The Journal of Clinical Endocrinology & Metabolism, 2000
- Parathyroid function in human vitamin D deficiency and vitamin D deficiency in primary hyperparathyroidismThe American Journal of Medicine, 1974
- VITAMIN-D DEFICIENCY AND PRIMARY HYPERPARATHYROIDISMThe Lancet, 1971